Andaxin en es it fr

Andaxin Brand names, Andaxin Analogs

Andaxin Brand Names Mixture

  • No information avaliable

Andaxin Chemical_Formula


Andaxin RX_link

No information avaliable

Andaxin fda sheet

Andaxin msds (material safety sheet)

Andaxin Synthesis Reference

No information avaliable

Andaxin Molecular Weight

309.469 g/mol

Andaxin Melting Point

< 25 oC

Andaxin H2O Solubility

Soluble as HCl salt

Andaxin State


Andaxin LogP


Andaxin Dosage Forms

Tablets (oral, 1 mg)

Andaxin Indication

Used for the symptomatic treatment of parkinsonism.

Andaxin Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Andaxin Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Andaxin side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Andaxin Patient Information

Andaxin Organisms Affected

Humans and other mammals